Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1729829 LONDON, X0
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,923,542
-$9,249,160 QoQ
Shares Held
134,410
-51.6% QoQ
Ownership
0.195%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. RYTM ranks #36 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 798,715 $240,437,176
2 INSM
INSMED Inc
 1,682,334 $179,370,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 221,607 $138,180,828
4 ROIV
Roivant Sciences Ltd.
 3,454,496 $122,254,613
5 AXSM
Axsome Therapeutics, Inc.
 426,336 $104,354,262
6
659,678 $87,559,060
7 TVTX
Travere Therapeutics, Inc.
 1,443,230 $81,989,896
8 RPRX
Royalty Pharma plc
 1,412,112 $79,177,119

All Filings in RYTM

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,923,542 134,410
2026-03-31 $24,172,702 277,943
2025-12-31 $33,280,769 310,919
2025-09-30 $24,118,330 238,819
2025-06-30 $15,187,400 240,345
2025-03-31 $11,451,743 216,193
2024-12-31 $5,331,255 95,235
2023-03-31 $5,197,041 291,314
2022-12-31 $5,257,819 180,557
2022-06-30 $119,495 28,794
2021-09-30 $201,816 15,453
2021-06-30 $454,725 23,224
2021-03-31 $567,398 26,676
2020-09-30 $329,015 15,183